Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1999 1
2000 3
2001 7
2002 4
2003 13
2004 13
2005 13
2006 17
2007 27
2008 20
2009 23
2010 16
2011 8
2012 15
2013 15
2014 12
2015 16
2016 14
2017 9
2018 8
2019 12
2020 9
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 17409312

239 results
Results by year
Filters applied: . Clear all
Page 1
Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.
Germain DP, Waldek S, Banikazemi M, Bushinsky DA, Charrow J, Desnick RJ, Lee P, Loew T, Vedder AC, Abichandani R, Wilcox WR, Guffon N. Germain DP, et al. J Am Soc Nephrol. 2007 May;18(5):1547-57. doi: 10.1681/ASN.2006080816. Epub 2007 Apr 4. J Am Soc Nephrol. 2007. PMID: 17409312 Free article. Clinical Trial.
Long-term safety and efficacy of enzyme replacement therapy for Fabry disease.
Wilcox WR, Banikazemi M, Guffon N, Waldek S, Lee P, Linthorst GE, Desnick RJ, Germain DP; International Fabry Disease Study Group. Wilcox WR, et al. Am J Hum Genet. 2004 Jul;75(1):65-74. doi: 10.1086/422366. Epub 2004 May 20. Am J Hum Genet. 2004. PMID: 15154115 Free PMC article. Clinical Trial.
Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.
Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ; International Collaborative Fabry Disease Study Group. Eng CM, et al. N Engl J Med. 2001 Jul 5;345(1):9-16. doi: 10.1056/NEJM200107053450102. N Engl J Med. 2001. PMID: 11439963 Free article. Clinical Trial.
Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial.
Ramaswami U, Bichet DG, Clarke LA, Dostalova G, Fainboim A, Fellgiebel A, Forcelini CM, An Haack K, Hopkin RJ, Mauer M, Najafian B, Scott CR, Shankar SP, Thurberg BL, Tøndel C, Tylki-Szymanska A, Bénichou B, Wijburg FA. Ramaswami U, et al. Mol Genet Metab. 2019 May;127(1):86-94. doi: 10.1016/j.ymgme.2019.03.010. Epub 2019 Apr 3. Mol Genet Metab. 2019. PMID: 30987917 Free article. Clinical Trial.
Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease.
Lubanda JC, Anijalg E, Bzdúch V, Thurberg BL, Bénichou B, Tylki-Szymanska A. Lubanda JC, et al. Genet Med. 2009 Apr;11(4):256-64. doi: 10.1097/GIM.0b013e3181981d82. Genet Med. 2009. PMID: 19265719 Free article. Clinical Trial.
Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease.
Wraith JE, Tylki-Szymanska A, Guffon N, Lien YH, Tsimaratos M, Vellodi A, Germain DP. Wraith JE, et al. J Pediatr. 2008 Apr;152(4):563-70, 570.e1. doi: 10.1016/j.jpeds.2007.09.007. Epub 2007 Dec 3. J Pediatr. 2008. PMID: 18346516 Clinical Trial.
Agalsidase alfa: a review of its use in the management of Fabry disease.
Keating GM. Keating GM. BioDrugs. 2012 Oct 1;26(5):335-54. doi: 10.2165/11209690-000000000-00000. BioDrugs. 2012. PMID: 22946754 Review.
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.
Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M, Finkel R, Packman S, Bichet DG, Warnock DG, Desnick RJ; Fabry Disease Clinical Trial Study Group. Banikazemi M, et al. Ann Intern Med. 2007 Jan 16;146(2):77-86. doi: 10.7326/0003-4819-146-2-200701160-00148. Epub 2006 Dec 18. Ann Intern Med. 2007. PMID: 17179052 Free article. Clinical Trial.
Enzyme replacement therapy for Fabry disease: a systematic review of available evidence.
Schaefer RM, Tylki-Szymańska A, Hilz MJ. Schaefer RM, et al. Drugs. 2009 Nov 12;69(16):2179-205. doi: 10.2165/11318300-000000000-00000. Drugs. 2009. PMID: 19852524 Review.
Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy.
Thurberg BL, Rennke H, Colvin RB, Dikman S, Gordon RE, Collins AB, Desnick RJ, O'Callaghan M. Thurberg BL, et al. Kidney Int. 2002 Dec;62(6):1933-46. doi: 10.1046/j.1523-1755.2002.00675.x. Kidney Int. 2002. PMID: 12427118 Free article. Clinical Trial.
239 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback